Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol

by Noordman, Bo Jan, Shapiro, Joel, Spaander, Manon CW, Krishnadath, Kausilia K, van Laarhoven, Hanneke WM, van Berge Henegouwen, Mark I, Nieuwenhuijzen, Grard AP, van Hillegersberg, Richard, Sosef, Meindert N, Steyerberg, Ewout W, Wijnhoven, Bas PL, van Lanschot, J Jan B
Published 2015-06-01